Nancy J Hutson
CIK 1379222 · last filed 2025-06-16
Nancy J Hutson is a corporate insider who has filed 105 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for BCRX, was dated Jun 16, 2025. Across all open-market trades the lifetime net is −$3.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $862.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$862.5K
7
105
-$3.83M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BCRX | Director | 99,138 | $8.70 | $862.5K | -$2.02M | 40 | 2025-06-16 |
| Clearside Biomedical, Inc. (CLSD) Delisted | Director | 93,000 | $0.35 | $32.7K | $90.3K | 12 | 2024-06-21 |
| PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Director | 37,760 | $0.07 | $2.6K | $22.9K | 9 | 2022-05-20 |
| Endo International plc (ENDP) Delisted | Director | 117,140 | $0.29 | $34.3K | -$605.2K | 21 | 2021-06-15 |
| CUBIST PHARMACEUTICALS INC (CBST.Z) Delisted | Director | 0 | — | — | -$585.0K | 2 | 2015-01-21 |
| CUBIST PHARMACEUTICALS INC (CBST) Delisted | Director | 9,847 | — | — | -$834.4K | 13 | 2013-07-29 |
| INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | Director | 0 | — | — | $98.4K | 7 | 2011-05-16 |
Recent Filings
105 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-16 | BCRX | Grant (A) | +12,500 | $0 | EDGAR |
| 2024-12-16 | BCRX | Sell (S) | −7,000 | -$52.8K | EDGAR |
| 2024-06-21 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | BCRX | Grant (A) | +6,820 | $0 | EDGAR |
| 2024-05-22 | BCRX | Buy (P) | +5,000 | $31.9K | EDGAR |
| 2023-10-04 | Clearside Biomedical, Inc. (CLSD) Delisted | Buy (P) | +10,000 | $8.6K | EDGAR |
| 2023-06-23 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-15 | BCRX | Mixed | +3,879 | -$103.4K | EDGAR |
| 2023-05-19 | — | Exer (M) | +3,750 | $0 | |
| 2022-11-21 | Clearside Biomedical, Inc. (CLSD) Delisted | Buy (P) | +30,000 | $39.9K | EDGAR |